Ignite Creation Date:
2024-05-06 @ 12:12 PM
Last Modification Date:
2024-10-26 @ 12:55 PM
Study NCT ID:
NCT03701711
Status:
TERMINATED
Last Update Posted:
2023-10-24
First Post:
2018-10-08
Brief Title:
Lenalidomide in Anti-MAG Neuropathy Phase 1b Study
Sponsor:
Ohio State University
Organization:
Ohio State University
Organization Data
Organization:
Ohio State University
Class:
OTHER
Study ID:
2018H0150
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ohio State University
Lead Sponsor Class:
OTHER
Responsible Party:
Bakri Elsheikh
Responsible Party Title:
Professor of Neurology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Ohio State University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |
| University of Michigan | OTHER |